Retinitis Pigmentosa (RP): Mechanisms and Restoration Strategies
active 🌍 PublicRetinitis Pigmentosa (RP) is a group of inherited retinal degenerative disorders that lead to progressive vision loss, primarily through the dysfunction and death of photoreceptor cells. Despite diverse genetic causes, all RP cases converge on disruption of the visual signal pipeline. Multiple therapeutic approaches aim to restore vision by targeting different layers of this pipeline. Core Question: How can vision be preserved, restored, or substituted in RP patients at different stages of degeneration?
This Week
What changed in your understanding?
Current State
No state snapshot yet. Capture the current state of this problem.
Edit state snapshot
Research Brief
Current Understanding
RP involves progressive photoreceptor degeneration across a visual signal pipeline: Light to Photoreceptors to Retinal Circuit to Optic Nerve to Visual Cortex. Therapeutic approaches target different layers of this pipeline depending on disease stage.
Most Promising Directions
Gene therapy for early-stage (mutation-specific) Optogenetics for mid-to-late stage (photoreceptor-independent) Stem cell replacement for mid-stage Retinal prosthetics and BCI for late-stage bypass
Open Unknowns
Which approaches scale across mutation types? Integration challenges for stem cell transplants Long-term safety of gene editing in retina Resolution limits of prosthetics vs optogenetics
Edit research brief
Where to Help
Which therapeutic approach is most scalable across different RP mutations?
Needs investigation
Can optogenetics achieve sufficient visual acuity for daily activities?
Needs investigation
How do combination therapies compare to single approaches?
Needs investigation
What is the realistic timeline for BCI-based vision restoration?
Needs investigation
What are the long-term safety profiles of retinal gene editing?
Needs investigation
Recent Activity
Hypothesis Tree
No hypotheses yet.
Add the first possible explanation or research direction.
Evidence & Resources
Open Questions
How do combination therapies compare to single approaches?
Can optogenetics achieve sufficient visual acuity for daily activities?
Which therapeutic approach is most scalable across different RP mutations?
Can stem cell-derived photoreceptors integrate into existing retinal circuits?
What are the long-term safety profiles of retinal gene editing?
What is the realistic timeline for BCI-based vision restoration?
Add a question
Recent Contributions
+ Add ContributionNo contributions yet.
Add the first structured research step to advance this problem.
Knowledge Base
+ Add ItemNo knowledge items yet.
Add papers, datasets, or notes that support this research.
🌱 Sub-Problems
Early-Stage RP Intervention (Photoreceptors Still Alive)
activeHow can photoreceptor function be preserved or restored when cells are still viable?
Mid-Stage RP Compensation (Partial Degeneration)
activeHow can remaining visual function be extended when some photoreceptors are lost?
Late-Stage RP Restoration (Photoreceptors Gone)
activeHow can vision be restored when photoreceptors are no longer functional?
Full Visual Bypass (Retina Non-Functional)
activeHow can visual perception be created without any functional retinal tissue?